ExodusPoint Capital Management’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-620,810
Closed -$10.2M 1808
2024
Q2
$10.2M Buy
620,810
+549,194
+767% +$8.4M 0.07% 250
2024
Q1
$1.01M Sell
71,616
-257,512
-78% -$3.88M 0.01% 940
2023
Q4
$5.67M Buy
+329,128
New +$5.03M 0.04% 316
2023
Q2
Sell
-14,930
Closed -$289K 2022
2023
Q1
$289K Buy
+14,930
New +$301K ﹤0.01% 1479
2022
Q4
Sell
-1,008,026
Closed -$21M 1836
2022
Q3
$21M Buy
1,008,026
+838,088
+493% +$21.3M 0.27% 62
2022
Q2
$4.74M Buy
169,938
+111,793
+192% +$3.32M 0.06% 426
2022
Q1
$1.82M Buy
58,145
+39,659
+215% +$1.25M 0.02% 828
2021
Q4
$617K Buy
+18,486
New +$617K 0.01% 1289
2021
Q3
Sell
-225,975
Closed -$6.03M 2339
2021
Q2
$6.03M Buy
225,975
+129,885
+135% +$3.67M 0.07% 281
2021
Q1
$2.65M Buy
96,090
+73,047
+317% +$2.04M 0.04% 465
2020
Q4
$635K Sell
23,043
-15,000
-39% -$396K 0.01% 1103
2020
Q3
$989K Buy
+38,043
New +$998K 0.02% 687

Other funds holding HR

ExodusPoint Capital Management's HR Position: Q3 2024 in Review

ExodusPoint Capital Management sold out of Healthcare Realty (HR) in Q3 2024, closing a stake of 620,810 shares — an estimated $10.2M sold.

ExodusPoint Capital Management first reported a position in HR in Q3 2020 and held it in 12 quarters. The position peaked at $21M in Q3 2022. 410 funds tracked by Wall St. Rank hold HR as of Q3 2024.

  • ExodusPoint Capital Management reported no remaining Healthcare Realty position as of Q3 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 620,810 Healthcare Realty shares in Q3 2024, an estimated $10.2M.
  • ExodusPoint Capital Management first reported a position in Healthcare Realty in Q3 2020 and held it in 12 quarters.
  • ExodusPoint Capital Management's Healthcare Realty position peaked at $21M in Q3 2022.
  • 410 funds tracked by Wall St. Rank held Healthcare Realty as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.